Illumina, Inc. (ILMN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

205.06

+17.82

(+9.52%)

At close: 04:00PM EDT

204.21

-0.85

(-0.41%)

After hours:

05:02PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	187.24
Open	196.48
Bid	201.30 x 1100
Ask	205.02 x 800
Day's Range	195.05 - 207.12
52 Week Range	173.45 - 428.00
Volume	2,674,839
Avg. Volume	1,586,879

Market Cap	32.867B
Beta (5Y Monthly)	1.16
PE Ratio (TTM)	46.18
EPS (TTM)	4.44
Earnings Date	Nov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	250.53

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Near Fair Value

6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ILMN

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Illumina, Inc.
Analyst Report: Illumina, Inc.Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Rating
Fair Value
Economic Moat
21 hours agoMorningstar